Back to Search Start Over

Evaluation of lipid profile status in metabolic syndrome.

Authors :
Shamaa Anjum, A.
Gayatri Devi, R.
Priya, Jothi
Savitha, G.
Source :
Drug Invention Today. Dec2018, Vol. 10 Issue 12, p2366-2369. 4p. 1 Chart, 3 Graphs.
Publication Year :
2018

Abstract

Introduction: Metabolic syndrome (MetS) is known as a group of cardiovascular risk factors associated with insulin resistance, hypertension, glucose intolerance, hypertriglyceridemia, and low levels of high-density lipoprotein cholesterol (HDL-C). It is a major worldwide public health problem. The aim of this study is to analyze the lipid profile status in MetS. Materials and Methods: Healthy individuals and individuals with MetS underwent serum analyzed for fasting blood sugar (FBS) by glucose oxidase-peroxidase method, serum cholesterol by cholesterol esterase-oxidase method, serum triglycerides by colorimetric enzymatic method, HDL-C by phosphotungtic acid method, low-density lipoprotein-cholesterol (LDL-C), and very LDL-C (VLDL-C) were calculated by Friedwald's formula and lipid profile status was compared between the two groups. Results: All the data were analyzed using the SPSS package. The mean value of FBS, triglyceride level, total cholesterol, HDL-C, LDL-C, and VLDL-C in individuals with MetS was found to be 105 ± 31.22, 151.1 ± 38.80, 191.15 ± 35.12, 20.7 ± 6.31, 140.3 ± 35.37, and 30.42 ± 6.76, respectively. Conclusion: From this study, it is evident that individuals with MetS have most of the risk factors that increase the person's risk of heart attack and stroke. Aside from the increase in waist circumference, most of the disorders associated with MetS have no symptoms. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09757619
Volume :
10
Issue :
12
Database :
Academic Search Index
Journal :
Drug Invention Today
Publication Type :
Academic Journal
Accession number :
132447020